FR2356427A2 - Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescin - Google Patents
Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescinInfo
- Publication number
- FR2356427A2 FR2356427A2 FR7620218A FR7620218A FR2356427A2 FR 2356427 A2 FR2356427 A2 FR 2356427A2 FR 7620218 A FR7620218 A FR 7620218A FR 7620218 A FR7620218 A FR 7620218A FR 2356427 A2 FR2356427 A2 FR 2356427A2
- Authority
- FR
- France
- Prior art keywords
- mucopolysaccharidases
- aescin
- hyaluronidase
- cpds
- triiodo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 title abstract 3
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 title abstract 3
- 108010003272 Hyaluronate lyase Proteins 0.000 title abstract 3
- 108010032809 mucopolysaccharidase Proteins 0.000 title abstract 3
- 102000001974 Hyaluronidases Human genes 0.000 title abstract 2
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000571 acetazolamide Drugs 0.000 title abstract 2
- 229960002773 hyaluronidase Drugs 0.000 title abstract 2
- 206010007882 Cellulitis Diseases 0.000 title 1
- UOWZUVNAGUAEQC-UHFFFAOYSA-N tiratricol Chemical compound IC1=CC(CC(=O)O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 UOWZUVNAGUAEQC-UHFFFAOYSA-N 0.000 title 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 229940122072 Carbonic anhydrase inhibitor Drugs 0.000 abstract 1
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The compsn. contains an association of mucopolysaccharidases opt. with hyaluronidase and >=1 of the active cpds. chosen from 3,5,3'-triiodo-thyroacetic acid or its esters and salts; 3,5,3'-triiodothyrobutyric acid or its esters and salts; acetozolamide and aescin. The mucopolysaccharidases and hyaluronidase enzymes hydrolyse the mucopolysaccharides and hyaluronic acid respectively allowing intercommunication of the cellulo-fatty tissue and lipid mobilisation and giving better penetration of cpds. applied to the skin and better diffusion of cpds. administered sub-cutaneously. Acetazolamide is a carbonic anhydrase inhibitor and regulates water-metabolism and the carbon dioxide present for the local synthesis of fatty acids. Aescin has casoprotective activity and avoids oedema formation.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7620218A FR2356427A2 (en) | 1976-07-02 | 1976-07-02 | Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescin |
| BE1008215A BE856006A (en) | 1976-07-02 | 1977-06-23 | NEW MEDICINES FOR THE TREATMENT OF LIPID OVERLOAD AND CELLULITE |
| DE2729010A DE2729010C2 (en) | 1976-07-02 | 1977-06-28 | Medicines for the treatment of cellulite and obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7620218A FR2356427A2 (en) | 1976-07-02 | 1976-07-02 | Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2356427A2 true FR2356427A2 (en) | 1978-01-27 |
| FR2356427B2 FR2356427B2 (en) | 1978-12-15 |
Family
ID=9175169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7620218A Granted FR2356427A2 (en) | 1976-07-02 | 1976-07-02 | Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescin |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE856006A (en) |
| DE (1) | DE2729010C2 (en) |
| FR (1) | FR2356427A2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2515961A1 (en) * | 1977-06-03 | 1983-05-13 | Berema Sa | MEDICAMENT PREPARATIONS CONTAINING A TETRAIODOTHYROCARBOXYLIC ACID DERIVATIVE, IN PARTICULAR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA |
| EP0477833A1 (en) * | 1990-09-28 | 1992-04-01 | Rosa Dr. Sternberg Ruiu | Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments |
| EP1398024A3 (en) * | 1995-06-07 | 2004-12-15 | Karo Bio Ab | uses for thyroid hormones compounds |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19721218B4 (en) * | 1997-05-21 | 2006-12-14 | Dornier Medizintechnik Gmbh | Using a pulse sound source |
| ATE245452T1 (en) * | 1998-12-23 | 2003-08-15 | Esparma Gmbh | HYALURONATE LYASE AS A PENETRATION PROMOTER IN TOPICAL AGENTS |
-
1976
- 1976-07-02 FR FR7620218A patent/FR2356427A2/en active Granted
-
1977
- 1977-06-23 BE BE1008215A patent/BE856006A/en not_active IP Right Cessation
- 1977-06-28 DE DE2729010A patent/DE2729010C2/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2515961A1 (en) * | 1977-06-03 | 1983-05-13 | Berema Sa | MEDICAMENT PREPARATIONS CONTAINING A TETRAIODOTHYROCARBOXYLIC ACID DERIVATIVE, IN PARTICULAR FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA |
| EP0477833A1 (en) * | 1990-09-28 | 1992-04-01 | Rosa Dr. Sternberg Ruiu | Composition for therapeutic and/or cosmetic use for treatment of circulatory diseases and for aesthetic medicine treatments |
| EP1398024A3 (en) * | 1995-06-07 | 2004-12-15 | Karo Bio Ab | uses for thyroid hormones compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2729010C2 (en) | 1986-11-06 |
| FR2356427B2 (en) | 1978-12-15 |
| DE2729010A1 (en) | 1978-01-12 |
| BE856006A (en) | 1977-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3806593A (en) | Hygienic-cosmetic compositions | |
| JPS567710A (en) | Whitening cosmetic | |
| TW337490B (en) | Skin-conditioning composition | |
| GB1505264A (en) | Implanting artificial hair | |
| ES8101385A1 (en) | Enzyme derivatives for use in the treatment of venous thrombosis, compositions containing them and their preparation. | |
| NO891379L (en) | ANESTHETIC SKIN MOISTURE PREPARATION AND PROCEDURE FOR PREPARING THEREOF. | |
| ATE141251T1 (en) | 4-DEMETHOXY-4-AMINO-ANTHRACYCLINE | |
| JPS6466118A (en) | Free fatty acid for treating or preventing chronic articular rheumatism | |
| ZA831083B (en) | Skin treatment composition | |
| IE40860L (en) | N- heterocyclylalkylbenzamides | |
| FR2356427A2 (en) | Compsn. for treatment of cellulitis and lipidic excess - contains mucopolysaccharidases opt. with hyaluronidase and active cpds. such as triiodo-thyroacetic acid, acetazolamide and aescin | |
| JPS567776A (en) | Diesterified compound of kojic acid | |
| GB1415023A (en) | Thiamphenicol derivatives | |
| IT1079830B (en) | IMPROVEMENT IN VALVE ARRANGEMENTS TO IMPROVE THE SUPPLY OF ALTERNATIVE ENDOTHERMAL MOTORS | |
| FR2230376A1 (en) | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity | |
| ES462498A1 (en) | Method for dissolving collagen-containing skin tissues | |
| Raekallio et al. | Histochemical demonstration of transglucosylases and glycogen in the “lag” phase of wound healing | |
| Robisch et al. | Differences in triacylglycerols from acoustic tissues and posterior cranial blubber of the narwhal (Monodon monoceros) | |
| GB903959A (en) | Improvements relating to the treatment of granular soils | |
| ES398932A1 (en) | Pyrrolidonecarboxylic acid alkyl esters - cosmetic agents | |
| FR2074627A1 (en) | Ppsoriasis treatment compsn | |
| JPS5522644A (en) | Hair restorer containing porphyrin compound | |
| GB955111A (en) | A new or improved cosmetic preparation for the treatment of the skin | |
| FR2142675A1 (en) | Triiodothyroalkanoic acid derivs - for treating lipid overload and celluitis | |
| FR2298321A1 (en) | Synergistic cinnarizine compsn - with clofibrate or clofibrinic acid and analogues with hypolipaemic activity |